Cargando…
Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357712/ https://www.ncbi.nlm.nih.gov/pubmed/35979174 http://dx.doi.org/10.1016/j.jot.2022.05.010 |
_version_ | 1784763770635026432 |
---|---|
author | Huang, Elijah Ejun Zhang, Ning Ganio, Edward A. Shen, Huaishuang Li, Xueping Ueno, Masaya Utsunomiya, Takeshi Maruyama, Masahiro Gao, Qi Su, Ni Yao, Zhenyu Yang, Fan Gaudillière, Brice Goodman, Stuart B. |
author_facet | Huang, Elijah Ejun Zhang, Ning Ganio, Edward A. Shen, Huaishuang Li, Xueping Ueno, Masaya Utsunomiya, Takeshi Maruyama, Masahiro Gao, Qi Su, Ni Yao, Zhenyu Yang, Fan Gaudillière, Brice Goodman, Stuart B. |
author_sort | Huang, Elijah Ejun |
collection | PubMed |
description | BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous bone graft is often insufficient in quantity or quality for transplantation to these large defects. Recently, tissue engineering methods using mesenchymal stem cells (MSCs) have been proposed as an alternative treatment. However, the underlying biological principles and optimal techniques for tissue regeneration of bone using stem cell therapy have not been completely elucidated. METHODS: In this study, we compare the early cellular dynamics of healing between bone graft transplantation and MSC therapy in a murine chronic femoral critical-size bone defect. We employ high-dimensional mass cytometry to provide a comprehensive view of the differences in cell composition, stem cell functionality, and immunomodulatory activity between these two treatment methods one week after transplantation. RESULTS: We reveal distinct cell compositions among tissues from bone defect sites compared with original bone graft, show active recruitment of MSCs to the bone defect sites, and demonstrate the phenotypic diversity of macrophages and T cells in each group that may affect the clinical outcome. CONCLUSION: Our results provide critical data and future directions on the use of MSCs for treating critical size defects to regenerate bone. Translational Potential of this article: This study showed systematic comparisons of the cellular and immunomodulatory profiles among different interventions to improve the healing of the critical-size bone defect. The results provided potential strategies for designing robust therapeutic interventions for the unmet clinical need of treating critical-size bone defects. |
format | Online Article Text |
id | pubmed-9357712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Chinese Speaking Orthopaedic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93577122022-08-16 Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect Huang, Elijah Ejun Zhang, Ning Ganio, Edward A. Shen, Huaishuang Li, Xueping Ueno, Masaya Utsunomiya, Takeshi Maruyama, Masahiro Gao, Qi Su, Ni Yao, Zhenyu Yang, Fan Gaudillière, Brice Goodman, Stuart B. J Orthop Translat Original Article BACKGROUND: A critical size bone defect is a clinical scenario in which bone is lost or excised due to trauma, infection, tumor, or other causes, and cannot completely heal spontaneously. The most common treatment for this condition is autologous bone grafting to the defect site. However, autologous bone graft is often insufficient in quantity or quality for transplantation to these large defects. Recently, tissue engineering methods using mesenchymal stem cells (MSCs) have been proposed as an alternative treatment. However, the underlying biological principles and optimal techniques for tissue regeneration of bone using stem cell therapy have not been completely elucidated. METHODS: In this study, we compare the early cellular dynamics of healing between bone graft transplantation and MSC therapy in a murine chronic femoral critical-size bone defect. We employ high-dimensional mass cytometry to provide a comprehensive view of the differences in cell composition, stem cell functionality, and immunomodulatory activity between these two treatment methods one week after transplantation. RESULTS: We reveal distinct cell compositions among tissues from bone defect sites compared with original bone graft, show active recruitment of MSCs to the bone defect sites, and demonstrate the phenotypic diversity of macrophages and T cells in each group that may affect the clinical outcome. CONCLUSION: Our results provide critical data and future directions on the use of MSCs for treating critical size defects to regenerate bone. Translational Potential of this article: This study showed systematic comparisons of the cellular and immunomodulatory profiles among different interventions to improve the healing of the critical-size bone defect. The results provided potential strategies for designing robust therapeutic interventions for the unmet clinical need of treating critical-size bone defects. Chinese Speaking Orthopaedic Society 2022-08-04 /pmc/articles/PMC9357712/ /pubmed/35979174 http://dx.doi.org/10.1016/j.jot.2022.05.010 Text en © 2022 Published by Elsevier B.V. on behalf of Chinese Speaking Orthopaedic Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Huang, Elijah Ejun Zhang, Ning Ganio, Edward A. Shen, Huaishuang Li, Xueping Ueno, Masaya Utsunomiya, Takeshi Maruyama, Masahiro Gao, Qi Su, Ni Yao, Zhenyu Yang, Fan Gaudillière, Brice Goodman, Stuart B. Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title | Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title_full | Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title_fullStr | Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title_full_unstemmed | Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title_short | Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
title_sort | differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357712/ https://www.ncbi.nlm.nih.gov/pubmed/35979174 http://dx.doi.org/10.1016/j.jot.2022.05.010 |
work_keys_str_mv | AT huangelijahejun differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT zhangning differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT ganioedwarda differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT shenhuaishuang differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT lixueping differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT uenomasaya differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT utsunomiyatakeshi differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT maruyamamasahiro differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT gaoqi differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT suni differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT yaozhenyu differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT yangfan differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT gaudillierebrice differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect AT goodmanstuartb differentialdynamicsofbonegrafttransplantationandmesenchymalstemcelltherapyduringbonedefecthealinginamurinecriticalsizedefect |